Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib cost?Allergan's patent for latisse expired?Pramlintide approval date?Mebendazole ingredients?Dabrafenib btd date 2023?
See the DrugPatentWatch profile for Spravato
Spravato, a nasal spray medication for treatment-resistant depression, was launched in the United States on March 12, 2019 [1].
Other Questions About Spravato :